➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Epidiolex

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Epidiolex?

Epidiolex is an investigational drug.

There have been 23 clinical trials for Epidiolex. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2019.

The most common disease conditions in clinical trials are Epilepsy, Syndrome, and Disease. The leading clinical trial sponsors are GW Research Ltd, GW Pharmaceuticals Ltd., and Anne Comi, MD.

There are eight hundred and two US patents protecting this investigational drug and four international patents.

Recent Clinical Trials for Epidiolex
Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate CancerZin W MyintPhase 1
A Study to Assess the Effect of Cannabidiol Oil on Pain After Ureteroscopy for Kidney StonesMayo ClinicPhase 2/Phase 3
CBD-Microglia PET StudyNational Center for Complementary and Integrative Health (NCCIH)Early Phase 1

See all Epidiolex clinical trials

Clinical Trial Summary for Epidiolex

Top disease conditions for Epidiolex
Top clinical trial sponsors for Epidiolex

See all Epidiolex clinical trials

US Patents for Epidiolex

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Epidiolex   Start Trial Pharmaceutical formulations GW Pharma Limited (Cambridge, GB)   Start Trial
Epidiolex   Start Trial Compositions and methods for treating chronic inflammation and inflammatory diseases Infirst Healthcare Limited (London, GB)   Start Trial
Epidiolex   Start Trial Method for treating hepatic encephalopathy or a disease associated with free radical mediate stress and oxidative stress with novel functionalized 1,3-benzene diols KANNALIFE SCIENCES, INC. (Huntington, NY)   Start Trial
Epidiolex   Start Trial METAP2 inhibitors and methods of treating obesity SynDevRx, Inc. (Cambridge, MA)   Start Trial
Epidiolex   Start Trial Compositions, uses and methods for making them   Start Trial
Epidiolex   Start Trial Pre-spray emulsions and powders containing non-polar compounds Virun, Inc. (Pomona, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Epidiolex

Drugname Country Document Number Estimated Expiration Related US Patent
Epidiolex Australia 2002231970 2021-02-14   Start Trial
Epidiolex Canada 2438097 2021-02-14   Start Trial
Epidiolex Canada 2533400 2021-02-14   Start Trial
Epidiolex China 1886117 2021-02-14   Start Trial
Epidiolex Cyprus 1115072 2021-02-14   Start Trial
Epidiolex Czech Republic 20032458 2021-02-14   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.